Doing now what patients need next
Roche, the largest biotech company, is a pioneer in healthcare and a frontrunner in personalized healthcare. Roche is the global leader in cancer treatments and the leading provider of in-vitro diagnostics. Moreover, Roche invests in innovation, offers an extraordinary workplace and acts in a sustainable way.
Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Roche believes in the importance of having a clear set of priorities to guide it through a turbulent and ever-changing environment. Its aim is to achieve long term sustainable growth and deliver value to all its stakeholders. The increased focus on innovation and biotechnology leads to important advances in diagnostic techniques and medicines aimed at molecular targets. As a result, many diseases can be detected earlier and treated more specifically. The full integration with biotech pioneer Genentech in 2009 follows acquisitions of other key players in life science research, gene sequencing and tissue diagnostics. These strengthen Roche’s access to innovation and new technologies and drive its commitment to more targeted treatments that, ultimately, make personalized healthcare a reality.